Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

SARS case-fatality rates

Wing K. Fung and Philip L.H. Yu
CMAJ August 19, 2003 169 (4) 277-278;
Wing K. Fung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip L.H. Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

A CMAJ editorial1 published in May 2003 cites the case-fatality rate for severe acute respiratory syndrome (SARS) in Canada as 12.4%. We have been examining death rates in Taiwan, Canada and Hong Kong2,3,4,5,6 and have found significant variation over time (Fig. 1, next page).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Fig. 1: Case-fatality rate for SARS in Taiwan, Canada and Hong Kong. 2 , 3 , 4 , 5 , 6

In Taiwan the first case of SARS was reported on Mar. 14, 2003;7 there were 78 cases by the end of April and 676 cases by the end of May.6 The first death was reported on Apr. 27, at which time the case-fatality rate (the number of deaths divided by the sum of deaths and recoveries) was only 3.8%. However, in mid-May the case-fatality rate rose markedly to a peak of about 45% and then stabilized at about 15% in June.

In Canada the first case of SARS was reported on Feb. 23 and the first 10 deaths were reported on Apr. 7. The case-fatality rate on that date was 38.5%; it fell to about 20% by the end of April and stabilized at about 17% in late June.

Finally, in Hong Kong case-fatality rates were very high (about 71%) early in the outbreak but later fell to about 17%.

According to recent data from Hong Kong,8 hospital death rates among patients at least 60 years of age peaked sharply at about 12 days after admission, whereas younger patients showed maximal (and lower) peak death rates at about 18 days. Thus, to understand the differences in case-fatality rates over time and between countries it is important to take age into account. Another factor that might explain initially high rates is physicians' lack of clinical experience with the disease early in the outbreak. Published reports9,10 suggest wide variation in therapy, which might also affect outcome. In addition, there has been considerable speculation that there may be different genetic forms of the virus (i.e., different degrees of virulence for the same virus) or that the virus has become less virulent over time.

Wing K. Fung Philip L.H. Yu Department of Statistics and Actuarial Science The University of Hong Kong Hong Kong, China

References

  1. 1.↵
    SARS: the struggle for containment [editorial]. CMAJ 2003;168(10):1229.
    OpenUrlFREE Full Text
  2. 2.↵
    Health Canada Online: SARS updates. Ottawa: Health Canada; 2003. Available: www.hc-sc.gc.ca/english/protection/warnings/sars/sars_update.htm (accessed 2003 Jul 21).
  3. 3.↵
    Health Canada Online: Summary of severe acute respiratory syndrome (SARS) cases: Canada and international. Available: www.hc-sc.gc.ca/pphb-dgspsp/sars-sras/eu-ae/index.html (accessed 2003 Jul 21).
  4. 4.↵
    News bulletin. Hong Kong: Hong Kong Department of Health; 2003. Available: www.info.gov.hk/dh/new/bulletin/bullet.htm (accessed 2003 Jul 22).
  5. 5.↵
    Issues of SARS News. Taiwan: Center for Disease Control, Department of Health; 2003. Available: www.cdc.gov.tw/En/ShowTopicText.ASP?TopicID=177 (accessed 2003 Jul 22).
  6. 6.↵
    Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization; 2003. Available: www.who.int/csr/sarscountry/en (accessed 2003 Jul 4).
  7. 7.↵
    Atypical pneumonia cases in Taiwan (2003/3/17). Taiwan: Center for Disease Control, Department of Health; 2003. Available: 203.65.72.83 /En /dpc /ShowPublication.ASP?RecNo=814 (accessed 2003 Jul 14).
  8. 8.↵
    Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003; 361: 1761-6. Available: image.thelancet .com /extras /03art4453web.pdf (accessed 2003 Jul 4).
    OpenUrlCrossRefPubMed
  9. 9.↵
    Parry J. SARS shows no sign of coming under control. BMJ 2003;326(7394):839.
    OpenUrlFREE Full Text
  10. 10.↵
    An appropriate response to SARS [editorial]. Lancet Infect Dis 2003;3:259.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 169 (4)
CMAJ
Vol. 169, Issue 4
19 Aug 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
SARS case-fatality rates
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
SARS case-fatality rates
Wing K. Fung, Philip L.H. Yu
CMAJ Aug 2003, 169 (4) 277-278;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
SARS case-fatality rates
Wing K. Fung, Philip L.H. Yu
CMAJ Aug 2003, 169 (4) 277-278;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The rationale of fever surveillance to identify patients with severe acute respiratory syndrome in Taiwan
  • SARS outbreak in the Greater Toronto Area: the emergency department experience
  • Google Scholar

More in this TOC Section

  • Hospital-at-home programs in Canada: challenges and pitfalls
  • Author response to “Pitfalls of analyzing perinatal outcomes by health care provider”
  • Pitfalls of analyzing perinatal outcomes by health care provider
Show more Letters

Similar Articles

Collections

  • Topics
    • Respiratory medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire